- €31.61m
- €25.12m
- €36.29m
- 92
- 44
- 26
- 54
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41.8 | 25.3 | 30.3 | 28.3 | 36.3 |
Cost of Revenue | |||||
Gross Profit | 18.5 | 13.2 | 15.9 | 17.6 | 20.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 37.4 | 24.5 | 26.1 | 32 | 38.5 |
Operating Profit | 4.41 | 0.732 | 4.23 | -3.69 | -2.25 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.755 | -2.93 | 4.13 | -3.78 | -2.32 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.203 | -6.97 | 4.12 | -3.3 | -1.31 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.203 | -6.97 | 7.19 | -1.31 | 0.108 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.203 | -6.97 | 7.19 | -1.31 | 0.108 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.252 | 0.024 | -0.045 | 0.004 |
Dividends per Share |